Other tuberculosis of meninges
ICD-10 A23.8 is a billable code used to indicate a diagnosis of other tuberculosis of meninges.
Other tuberculosis of meninges refers to a rare form of tuberculosis that primarily affects the protective membranes covering the brain and spinal cord, known as the meninges. This condition is often a result of hematogenous spread from a primary site of infection, typically the lungs, but can also arise from extrapulmonary sources. Symptoms may include severe headaches, fever, neck stiffness, and altered mental status. Diagnosis is typically confirmed through imaging studies such as MRI or CT scans, along with lumbar puncture to analyze cerebrospinal fluid (CSF) for the presence of Mycobacterium tuberculosis. Treatment involves a prolonged course of antitubercular medications, often requiring a combination of isoniazid, rifampicin, ethambutol, and pyrazinamide. Given the potential for severe neurological complications, early recognition and treatment are critical to improving patient outcomes. Public health considerations include monitoring for zoonotic transmission, particularly in areas where tuberculosis is endemic, and ensuring adequate vaccination and screening programs are in place to prevent outbreaks.
Detailed patient history, laboratory results, and treatment plans must be documented.
Patients presenting with neurological symptoms and a history of tuberculosis.
Ensure that all relevant tests and imaging studies are documented to support the diagnosis.
Neurological assessments, imaging results, and CSF analysis must be clearly documented.
Patients with altered mental status and signs of meningitis.
Document any differential diagnoses considered and ruled out.
Used to obtain CSF for analysis in suspected cases of meningitis.
Document indication for the procedure and results of CSF analysis.
Neurology specialists should ensure thorough documentation of neurological assessments.
Common symptoms include severe headaches, fever, neck stiffness, altered mental status, and neurological deficits.
Diagnosis is typically made through a combination of clinical evaluation, imaging studies, and analysis of cerebrospinal fluid obtained via lumbar puncture.
Treatment usually involves a multi-drug regimen including isoniazid, rifampicin, ethambutol, and pyrazinamide, often for an extended duration.
